EB-2 NIW Appeals: Pharmacy

Last updated 2026-09-02

The AAO dismissed 90.0% of EB-2 NIW appeals from Pharmacy petitioners in published non-precedent decisions from 2022–2025 (n=20). The criterion most often at issue was Prong 1: Substantial merit and national importance.

Outcomes by Year

YearDismissedSustainedRemandedTotal
20251 (—)001
202412 (—)0012
20235 (—)016
20220 (—)011

Criteria Breakdown

CriterionIn DismissedIn SustainedTotalDismissal Rate
Prong 1: Substantial merit and national importance2402596.0%
Prong 2: Well positioned to advance the endeavor16017—
Prong 3: On balance, waiver benefits the U.S.13014—

Example Decisions

Dismissed2025-02-07The appeal was dismissed because the petitioner failed to establish that the proposed endeavor was of national importanc Dismissed2024-10-21The appeal was dismissed because the petitioner failed to demonstrate the 'national importance' of the beneficiary's pro Dismissed2024-05-28The appeal was dismissed because the petitioner failed to demonstrate that his proposed endeavor had 'national importanc Dismissed2024-11-18The appeal was dismissed because the petitioner failed to establish that the beneficiary's proposed endeavor has nationa Dismissed2024-07-10The appeal was dismissed because the petitioner failed to establish the 'national importance' of his proposed endeavor u
NYSDOT-era decisions (pre-2017)

Outcomes by Year

YearDismissedSustainedRemandedTotal
20122 (—)002
20090 (—)101
20081 (—)001

Criteria Discussed

CriterionIn DismissedIn SustainedTotal
Intrinsic merit (NYSDOT)314
National in scope (NYSDOT)314
Substantially greater degree than U.S. worker (NYSDOT)314

Sample: published AAO non-precedent decisions collected from uscis.gov. EB-2 NIW statistics reflect the Dhanasar framework era (2022–2025); the prior NYSDOT framework applied different legal standards. These are appeals, not all USCIS adjudications; approval rates here are not initial-filing approval rates. Read our full methodology.

Filing your own EB-2 NIW? See how your CV maps to the criteria — free strategy preview.
Get Your Free Strategy Preview →